Gufic Biosciences Limited (BOM:509079)

Gufic Biosciences Statistics

Total Valuation

BOM:509079 has a market cap or net worth of INR 36.40 billion. The enterprise value is 39.47 billion.

Market Cap	36.40B
Enterprise Value	39.47B

Important Dates

The last earnings date was Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	Sep 17, 2024

Share Statistics

BOM:509079 has 100.28 million shares outstanding. The number of shares has increased by 0.87% in one year.

Current Share Class	100.28M
Shares Outstanding	100.28M
Shares Change (YoY)	+0.87%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	43.39%
Owned by Institutions (%)	6.80%
Float	25.79M

Valuation Ratios

The trailing PE ratio is 58.84.

PE Ratio	58.84
Forward PE	n/a
PS Ratio	4.33
PB Ratio	6.06
P/TBV Ratio	6.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	63.80
EV / Sales	4.69
EV / EBITDA	29.98
EV / EBIT	36.63
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.56
Debt / EBITDA	2.55
Debt / FCF	n/a
Interest Coverage	3.89

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	7.47%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	5.64M
Profits Per Employee	414,915
Employee Count	1,491
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BOM:509079 has paid 214.50 million in taxes.

Income Tax	214.50M
Effective Tax Rate	25.75%

Stock Price Statistics

The stock price has increased by +2.30% in the last 52 weeks. The beta is 0.14, so BOM:509079's price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	+2.30%
50-Day Moving Average	365.81
200-Day Moving Average	390.32
Relative Strength Index (RSI)	45.92
Average Volume (20 Days)	3,416

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:509079 had revenue of INR 8.41 billion and earned 618.64 million in profits. Earnings per share was 6.17.

Revenue	8.41B
Gross Profit	4.60B
Operating Income	1.08B
Pretax Income	833.13M
Net Income	618.64M
EBITDA	1.32B
EBIT	1.08B
Earnings Per Share (EPS)	6.17

Balance Sheet

The company has 290.22 million in cash and 3.36 billion in debt, giving a net cash position of -3.07 billion or -30.63 per share.

Cash & Cash Equivalents	290.22M
Total Debt	3.36B
Net Cash	-3.07B
Net Cash Per Share	-30.63
Equity (Book Value)	6.01B
Book Value Per Share	59.96
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 54.71%, with operating and profit margins of 12.81% and 7.36%.

Gross Margin	54.71%
Operating Margin	12.81%
Pretax Margin	9.91%
Profit Margin	7.36%
EBITDA Margin	15.66%
EBIT Margin	12.81%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.03%.

Dividend Per Share	0.10
Dividend Yield	0.03%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	1.62%
Buyback Yield	-0.87%
Shareholder Yield	-0.85%
Earnings Yield	1.70%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2002. It was a forward split with a ratio of 10.

Last Split Date	Oct 29, 2002
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2